V. Piguet, “Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes from an Ongoing Phase 3, Multicenter, Randomized, Active- and Placebo-Controlled Study (CIMPACT)”, J of Skin, vol. 1, no. 3.1, p. s3, Oct. 2017.